Stayble Therapeutics Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Catharina Bäärnhielm Marklund, was filed 06 Mar 2020.
Stayble Therapeutics: what insiders have been doing
Stayble Therapeutics is a listed company. Its insiders report their share dealings to Finansinspektionen. No insider at Stayble Therapeutics has published a filing in the past twelve months. The most recent one dates from 9 March 2020.
Since 2020, the database holds 2 purchases and no sales by insiders of the company.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Financial data
· cache
- 250,000 shares0AktieISIN SE0013513652FI:csv-e56aff37dcf0c624bc28
- 30,000 shares0AktieISIN SE0013513652FI:csv-e69583535a22a8c42683
- 4,000 shares@ SEK 12.30100.0% of flowAktieISIN SE0013513652FI:csv-026298af7cf815d01874Canonical exit: 25 May 2020 (T+90)
- 4,000 shares0TeckningsoptionISIN SE0013748381FI:csv-6edf9efcee3922e6616aCanonical exit: 25 May 2020 (T+90)
4 of 4 declarations
About Stayble Therapeutics
Stayble Therapeutics is a company focused on developing treatments for chronic pain disorders. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations